Binding and endocytosis of murine high density lipoprotein from healthy (HDL) and inflamed donors (HDLSAA) by murine macrophages in vitro. A light and electronmicroscopic investigation

Amyloid

Volumn 4, Issue 4, 1997, Pages 259-273

  Röcken, Christoph ^a,b   Kisilevsky, Robert ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Amyloid; Endocytosis; High density lipoprotein; Macrophage

Indexed keywords

EID: 0000164586     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129709003837     Document Type: Article

References (57)

1. Husby G, Marhaug G, Dowton B, Sletten K and Sipe JD (1994). Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis. Amyloid Int J Exp Clin Invest 1,119-137
2. Malle E, Steinmetz A and Raynes JG (1993). Serum Amyloid A (SAA) - An acute phase protein and apolipoprotein. Atherosclerosis, 102,131-146
3. Glenner GG (1980). Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med, 302,1283-1292
4. Glenner GG (1980). Amyloid deposits and amyloidosis. The β-fibrilloses. N Engl J Med, 302,1333-1343
5. Husebekk A, Skogen B, Husby G and Marhaug G (1985). Transformation of amyloid precurser SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 21,283-287
6. Tape C, Tan R, Nesheim M and Kisilevsky R (1988). Direct evidence for circulating apoSAA as the precursor of tissue AA amyloid deposits. Scand J Immunol 28,317-324
7. Kisilevsky R, Narindrasorasak S, Tape C, Tan R and Boudreau L (1994). During AA amyloidogenesis is proteolytic attack on serum amyloid A a pre- or post-fibrillogenic event? Amyloid Int J Exp Clin Invest 1,174-183
8. Shirahama TS and Cohen AS (1975). Intralysosomal formation of amyloid fibrils. Amer J Pathol 81,101-116
9. Takahashi M, Yokota T, Kawano H, Gondo T, Ishihara T and Uchino F (1989). Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages. Virchows Arch A Pathol Anat Histopathol 415,411-419
10. Miura K, Ju ST, Cohen AS and Shirahama T (1990). Generation and use of site-specific antibodies to serum amyloid-A for probing amyloid A development. J Immunol 144,610-613
11. Chronopoulos S, Chan SL, Ratcliffe MJH and Ali-Khan Z (1995). Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes: A double immunogold electron microscopic study. Amyloid Int J Exp Clin Invest 2,191-194
12. Takahashi K, Fukuda S, Naito M, Horiuchi S, Takata K and Morino Y (1989). Endocytic pathway of high density lipoprotein via trans-golgi system in rat resident peritoneal macrophages. Lab Invest 61,270-277
13. Schmitz G, Robenek H, Lohmann U and Assmann G (1985). Interaction of high density lipoproteins with cholesteryl ester-laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis, and resecretion of high density lipoproteins by macrophages. EMBO J 4,613-622
14. Pastan IH and Willigham MC (1981). Journey to the center of the cell: role of the receptosome. Science 214,505-509
15. Wileman T, Harding C and Stahl P (1985). Receptor-mediated endocytosis. Biochem J 232,1-14
16. Havel RJ and Hamilton RL (1988). Hepatocytic lipoprotein receptors and intracellular lipoprotein catabolism. Hepatology 8, 1689-1704
17. Kelly JW and Lansbury PT (1994). A chemical approach to elucidate the mechanism of transthyretin and b-protein amyloid fibril formation. Amyloid Int J Exp Clin Invest 1, 86-205
18. Bekaert ED, Dole E, Dubois DY, Bouma ME, Lontie JF, Kallel R, Malmendier CL and Ayrault-Jarrier M (1992). Alterations in lipoprotein density classes in infantile visceral leishmaniasis - Presence of apolipoprotein SAA. Eur J Clin Invest 22,190-199
19. Blackman JD, Cabana VG and Mazzone T (1993). The acute-phase response and associated lipoprotein abnormalities accompanying lymphoma. J Intern Med 233,201-204
20. Cabana VG, Siegel JN and Sabesin SM (1989). Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 30,39-49
21. Gonnerman WA, Cathcart ES, and Sipe JD (1990). Increased binding of acute phase lipoproteins by peritoneal macrophages (Mfs) in mice. In: Natvig J, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P. Amyloid and Amyloidosis 1990. Kluwer Academic Publishers, London, pp 547-550
22. Kisilevsky R and Subrahmanyan L (1992). Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 66,778-785
23. Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK and de Beer FC (1995). Serum amyloid A (SAA): Influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 36,1058-1065
24. Gonnerman WA, Lim M, Sipe JD, Hayes KC and Cathcart ES (1997). The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism. Amyloid Int J Exp Clin Invest 3,261-269
25. La Ville AE, Sola R, Balanya J, Turner PR and Masana L (1994). In vitro oxidised HDL is recognised by the scavenger receptor of macrophages - Implications for its protective role in vivo. Atherosclerosis 105,179-189
26. Handley DA, Arbeeny CM, Witte LD and Chien S (1981). Colloidal gold-low density lipoprotein conjugates as membrane receptor probes. Proc Natl Acad Sci USA 78,368-371
27. Hoffman JS and Benditt EP (1982). Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. J Biol Chem 257,10510-10517
28. LeBoeuf RC, Puppione DL, Schumaker VN and Lusis AJ (1983). Genetic control of lipid transport in mice. I. Structural properties and polymorphisms of plasma lipoproteins. J Biol Chem 258,5063-5070
29. de Silva HV, Mas-Oliva J, Taylor JM and Mahley RW (1994). Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse. J Lipid Res 35,297-1310
30. Ji ZS, Brecht WJ, Miranda RD, Hussain M, Innerarity TL and Mahley RW (1993). Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem 268,10160-10167
31. Anderson RGW (1986). Methods for visualization of the LDL pathway in cultured human fibroblasts. Meth Enzymol 129,201-216
32. Röcken C (1992). Lichtmikroskopische Untersuchung der Rezeptor-vermittelten Endozytose des Low Density Lipoproteins (LDL) an kultivierten Tumorzellen. PhD Dissertation University of Hamburg, Germany
33. Login GR, Galli SJ and Dvorak AM (1992). Immunocytochemical localization of histamine in secretory granules of rat peritoneal mast cells with conventional rapid microwave fixation and an ultrastructural post-embedding immunogold technique. J Histochem Cytochem 40,1247-1256
34. Login GR, Ku TC and Dvorak AM (1995). Rapid primary microwave-aldehyde and microwave-osmium fixation: improved detection of rat parotid acinar secretory granule alpha-amylase using a post-embedding immunogold ultrastructural morphometric analysis. J Histochem Cytochem 43,515-523
35. Nicholson AC, Frieda S, Pearce A and Silverstein RL (1995). Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb 15,269-275
36. Ji ZS, Fazio S, Lee YL and Mahley RW (1994). Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J Biol Chem 269,2764-2772
37. Mahley RW, Ji ZS, Brecht WJ, Miranda RD and He D (1994). Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant lipoprotein metabolism. Ann N Y Acad Sci 737,39-52
38. Edwards IJ, Xu HZ, Obunike JC, Goldberg IJ and Wagner WD (1995). Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol 15,400-409
39. Vijayagopal P (1994). Regulation of the metabolism of lipoprotein-proteoglycan complexes in human monocyte-derived macrophages. Biochem J 301,675-681
40. Allan CM, Fidge NH, Morrison JR and Kanellos J (1993). Monoclonal antibodies to human apolipoprotein AI - Probing the putative receptor binding domain of apolipoprotein AI. Biochem J 290,449-455
41. Yura H, Goto M and Akaike T (1995). Receptor-mediated interaction of the low-density lipoprotein complex with dextran sulfate: potential as a multi-biological coupler. J Biochem Tokyo 118,700-705
42. Braun JEA and Severson DL (1992). Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J 287,337-347
43. Hopkins CR, Gibson A, Shipman M and Miller K (1990). Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature 346,335-339
44. Nixon RA and Cataldo AM (1995). The endosomal-lysosomal system of neurons: new roles. Trends Neurosci 18,489-496
45. Yamada T, Kluve-Beckerman B, Liepnieks JJ and Benson MD (1995). In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: Possible protection against amyloid fibril formation. Scand J Immunol 41,510-574
46. Yamada T, Liepnieks JJ, Kluve-Beckerman B and Benson MD (1995). Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A. Scand J Immunol 41,94-97
47. Chronopoulos S, Laird DW, and Ali-Khan Z (1994). Immunolocalization of serum amyloid A and AA amyloid in lysosomes in murine monocytoid cells. J Pathol 173,361-369
48. Chronopoulos S, Chan SL, Ratcliffe MJH, and Ali-Khan Z (1995). Colocalization of ubiquitin and serum amyloid A and ubiquitin-bound AA in the endosomes-lysosomes: A double immunogold electron microscopic study. Amyloid Int J Exp Clin Invest 2,191-194
49. Yamada T, Liepnicks J, Benson MD, and Kluve-Beckerman B (1996). Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin. J Immunol 157,910-907
50. Mahley RW (1988). Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240,622-630
51. Deng J, Rudick V and Dory L (1995). Lysosomal degradation and sorting of apolipoprotein E in macrophages. J Lipid Res 36,2129-2140
52. Kraemer FB (1992). Role of lipoprotein lipase and apolipoprotein E secretion by macrophages in modulating lipoprotein uptake. Possible role in acceleration of atherosclerosis in diabetes. Diabetes 41 Suppl 2,77-80
53. Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T and Nakai T (1995). Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J Biol Chem 270,15747-15754
54. Liao W (1995). β-migrating very-low-density lipoprotein, chylomicron remnants and their receptors. Biochem J 310,359-365
55. Kindy MS, King AR, Perry G, DeBeer MC and DeBeer FC (1995). Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest 73,469-475
56. Kisilevsky R (1990). Heparan sulfate proteoglycans in amyloidogenesis - An epiphenomenon, a unique factor, or the tip of a more fundamental process. Lab Invest 63,589-591
57. Castano EM, Prelli FC and Frangione B (1995). Apolipoprotein E and amyloidogenesis. Lab Invest 73,457-460